| scholarly article | Q13442814 |
| P2093 | author name string | Paulus W | |
| Roggendorf W | |||
| Huettner C | |||
| P2860 | cites work | Involvement of Nitric Oxide on the Cytokine-Induced Growth of Glial Cell | Q57080129 |
| Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas | Q59077136 | ||
| Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control | Q67907340 | ||
| Identification and induction of keratinocyte-derived IL-10 | Q68159676 | ||
| Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas | Q69741947 | ||
| Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor | Q70482927 | ||
| Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin | Q24299103 | ||
| Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI | Q24312126 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes | Q29619621 | ||
| Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones | Q29622840 | ||
| Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression | Q34504988 | ||
| The role of IL-10 in crossregulation of TH1 and TH2 responses | Q36401295 | ||
| A new view of prostaglandin E regulation of the immune response. | Q37543272 | ||
| Modulation of T-cell function by gliomas | Q37543281 | ||
| Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction | Q37733390 | ||
| Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression | Q41533477 | ||
| Human glioblastoma cells release interleukin 6 in vivo and in vitro | Q41718103 | ||
| Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia | Q42512061 | ||
| Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes | Q42601376 | ||
| Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers | Q46049205 | ||
| Cytokine gene expression by human gliomas. | Q55484587 | ||
| Prostaglandin and thromboxane synthesis by human intracranial tumors. | Q55485457 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 317-322 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas | |
| P478 | volume | 146 |
| Q38753736 | Advanced age negatively impacts survival in an experimental brain tumor model. |
| Q35781959 | An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals |
| Q38603909 | An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors |
| Q27024830 | An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma |
| Q48145621 | Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumors |
| Q55475931 | CNTF and its receptor subunits in human gliomas. |
| Q36625030 | Cell mediated immunity in human pathology: the importance of choosing the right weapon |
| Q37640613 | Challenges in clinical design of immunotherapy trials for malignant glioma |
| Q47719808 | Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. |
| Q61882072 | Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression |
| Q37886819 | Cytokine networks in glioma |
| Q34603835 | Deltex-1 activates mitotic signaling and proliferation and increases the clonogenic and invasive potential of U373 and LN18 glioblastoma cells and correlates with patient survival |
| Q55477326 | Down-regulation of transforming growth factor-beta and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs. |
| Q34276759 | Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors. |
| Q40979862 | Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10. |
| Q48746787 | Glioblastoma in multiple sclerosis: a case report |
| Q38355702 | Glioblastoma stem cells and stem cell-targeting immunotherapies. |
| Q64110950 | Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma |
| Q55463659 | IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas. |
| Q26765855 | Immune Evasion Strategies of Glioblastoma |
| Q26798402 | Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites |
| Q37267793 | Immunotherapeutic approaches for glioma |
| Q26866513 | Immunotherapy advances for glioblastoma |
| Q38953024 | Improving vaccine efficacy against malignant glioma |
| Q40738671 | Interleukin-6-producing cells in a human glioblastoma cell line are not affected by ionizing radiation |
| Q61882075 | Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix |
| Q39480423 | Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma. |
| Q90218743 | Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas |
| Q48136285 | Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas |
| Q39043417 | Novel vaccines for glioblastoma: clinical update and perspective |
| Q52659651 | Paclitaxel treatment and PC1/3 knockdown in macrophages is a promising anti-glioma strategy as revealed by proteomics and cytotoxicity studies. |
| Q55457286 | Quo Vadis-Do Immunotherapies Have a Role in Glioblastoma? |
| Q35992355 | Recent developments on immunotherapy for brain cancer |
| Q41198335 | Rescuing defective tumor-infiltrating T-cell proliferation in glioblastoma patients |
| Q92881504 | Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma |
| Q35800798 | Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer. |
| Q33833226 | Th1/Th2 balance in cancer, transplantation and pregnancy |
| Q38008966 | The molecular profile of microglia under the influence of glioma |
| Q42571106 | The paradox of IL-10-mediated modulation in cervical cancer |
Search more.